Previous studies showed that fasudil reduced the growth of hepatocellular carcinoma tumours driven by expression of oncogenic NRas plus over-expressed Akt [42], consistent with the observation that fasudil reduced the tumour number, area and volumes induced by DEN in Figure 5. Here, NRAS is linked to hepatocellular carcinoma.